Based on our previous work, we hypothesized that more differentiated cells, expressing high levels of GFAP, would be less clonogenic in vitro and may give rise to less aggressive tumors or even fail to form tumor xenografts in vivo as compared to less differentiated cells which express low levels of GFAP. This evidence concerns the gene GFAP and neoplasm.